Sanofi
PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN
Last updated:
Abstract:
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
Status:
Application
Type:
Utility
Filling date:
26 Dec 2019
Issue date:
29 Oct 2020